The Mechanism of MicroRNAs Network in Alzheimer's Disease
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Diagnostic Test: MicRNAs test
- Registration Number
- NCT05055310
- Lead Sponsor
- Shanghai Mental Health Center
- Brief Summary
MicroRNAs network, such as MicRNA107 et al, regulate the pathology of Alzheimer's disease and the clinical validation in diagnosis AD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- NIA-AA MCI due to AD clinical criteria for MCI due to AD
- NIA-AA AD clinical criteria for AD
Exclusion Criteria
- Other type of dementia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Normal elderly MicRNAs test normal cognitive group aMCI MicRNAs test amnestic mild cognitive impairment AD MicRNAs test Alzhiemer's disease
- Primary Outcome Measures
Name Time Method MicRNAs diagnosis validation for aMCI 5 years MicRNAs concentration in plasma among three groups
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Psychogeriatrics，Shanghai Mental Health Center
🇨🇳Shanghai, Shanghai, China